Clinical course and outcome for critically ill children with Down syndrome: A retrospective cohort study

Intensive Care Medicine

Volumn 38, Issue 8, 2012, Pages 1365-1371

  Tibby, Shane M ^a   Durward, Andrew ^a   Goh, Chong Tien ^b   Thorburn, Kentigern ^c   Morris, Kevin ^d   Broadhead, Mike ^b   Peters, Mark J ^b,e  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Competing risks; Critical care; Down syndrome; Multiple organ failure; Outcome

Indexed keywords

ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR;

CARDIOTONIC AGENTS; CHILD, PRESCHOOL; COHORT STUDIES; CRITICAL ILLNESS; DOWN SYNDROME; FEMALE; HEART DISEASES; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MULTIPLE ORGAN FAILURE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84864287829     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2589-x     Document Type: Article

References (30)

1. Bittles AH, Bower C, Hussain R, Glasson EJ (2007) The four ages of Down syndrome. Eur J Public Health 17:221-225 (Pubitemid 46536733)
2. Ross JA, Spector LG, Robison LL, Olshan AF (2005) Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer 44:8-12 (Pubitemid 39602559)
3. Lott IT, Dierssen M (2010) Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 9:623-633
4. Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359:1019-1025 (Pubitemid 34286539)
5. Michielon G, Marino B, Oricchio G, Digilio MC, Iorio F, Filippelli S, Placidi S, Di Donato RM (2009) Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J Thorac Cardiovasc Surg 138:565-570 e2
6. Fudge JC Jr, Li S, Jaggers J, óBrien SM, Peterson ED, Jacobs JP, Welke KF, Jacobs ML, Li JS, Pasquali SK (2010) Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics 126:315-322
7. Bruijn M, van der Aa LB, van Rijn RR, Bos AP, van Woensel JB (2007) High incidence of acute lung injury in children with Down syndrome. Intensive Care Med 33:2179-2182 (Pubitemid 350164553)
8. Garrison MM, Jeffries H, Christakis DA (2005) Risk of death for children with Down syndrome and sepsis. J Pediatr 147:748-752 (Pubitemid 41774829)
9. Proulx F, Gauthier M, Nadeau D, Lacroix J, Farrell CA (1994) Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 22:1025-1031 (Pubitemid 24182736)
10. Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS (1986) Outcome of pediatric patients with multiple organ system failure. Crit Care Med 14:271-274 (Pubitemid 16102041)
11. Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM (1987) Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111:324-328 (Pubitemid 17157499)
12. Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408-2416 (Pubitemid 47476242)
13. Mongardon N, Dyson A, Singer M (2009) Is MOF an outcome parameter or a transient, adaptive state in critical illness? Curr Opin Crit Care 15:431-436
14. Singer M, De Santis V, Vitale D, Jeffcoate W (2004) Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:545-548 (Pubitemid 39070417)
15. Pallardó FV, Degan P, d'Ischia M, Kelly FJ, Zatterale A, Calzone R, Castello G, Fernandez-Delgado R, Dunster C, Lloret A, Manini P, Pisanti MA, Vuttariello E, Pagano G (2006) Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology 7:211-220
16. Hawli Y, Nasrallah M, El-Hajj Fuleihan G (2009) Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 5:327-334
17. http://www.picanet.org.uk/. Accessed 30 April 2011
18. PICANET REPORT (2003-2004). http://www.picanet.org.uk/documentation.html. Accessed 8 May 2012
19. Pintile M (2006) Competing risks: a practical perspective. Wiley-Blackwell. ISBN-10: 0470870680
20. Royston P, Altman DG (1994) Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling. Appl Stat 43:429-467
21. Slater A, Shann F, Pearson G (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278-285 (Pubitemid 36384419)
22. Balfour-Lynn IM, Tasker RC (1996) At the coalface-medical ethics in practice. Futility and death in paediatric medical intensive care. J Med Ethics 22:279-281 (Pubitemid 26385482)
23. Azevedo LC (2010) Mitochondrial dysfunction during sepsis. Endocr Metab Immune Disord Drug Targets 10:214-223
24. Singer M (2007) Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 35(9 Suppl):S441-S448 (Pubitemid 47312177)
25. Carré JE, Orban JC, Re L, Felsmann K, Iffert W, Bauer M, Suliman HB, Piantadosi CA, Mayhew TM, Breen P, Stotz M, Singer M (2010) Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 182:745-751
26. Zitnanová I, Korytár P, Aruoma OI, Sustrová M, Garaiová I, Muchová J, Kalnovicová T, Pueschel S, Duracková Z (2004) Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms? Clin Chim Acta 341:139-146 (Pubitemid 38210325)
27. Clementi E, Brown GC, Feelisch M, Moncada S (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95:7631-7636 (Pubitemid 28293304)
28. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441(7093):595-600 (Pubitemid 43927286)
29. Hermann-Kleiter N, Baier G (2010) NFAT pulls the strings during CD4? T helper cell effector functions. Blood 115:2989-2997
30. Minami T, Yano K, Miura M, Kobayashi M, Suehiro J, Reid PC, Hamakubo T, Ryeom S, Aird WC, Kodama T (2009) The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J Clin Invest 119:2257-2270